Elevated mRNA-Levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's Disease transgenic mice

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Nuruddin, Syed ^a   Syverstad, Gry Helen Enger ^b   Lillehaug, Sveinung ^b   Leergaard, Trygve B ^b   Nilsson, Lars N G ^b,d   Ropstad, Erik ^a   Krogenæs, Anette ^a   Haraldsen, Ira Ronit Hebold ^c   Torp, Reidun ^b  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GONADORELIN; GONADORELIN RECEPTOR; LEUPRORELIN; MESSENGER RNA; AMYLOID BETA PROTEIN; ESTRADIOL; TESTOSTERONE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GNRH GENE; GNRHR GENE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; THALAMUS; ANIMAL; BLOOD; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE, TRANSGENIC; PLAQUE, AMYLOID; RECEPTORS, LHRH; RNA, MESSENGER; TESTOSTERONE;

EID: 84905472512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103607     Document Type: Article

References (45)

1. Wimo A, Jönsson L, Bond J, Prince M, Winblad B (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 9: 1-11.
2. Wimo A, Winblad B, Jönsson L (2007) An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement 3: 81-91. (Pubitemid 46586163)
3. Francis PT, Parsons CG, Jones RW (2012) Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease. Expert Rev Neurotherapeutics 12: 1351-1365.
4. Selkoe DJ (1997) Alzheimer's disease: genotypes, phenotype, and treatments. Science 275: 630-631.
5. Verri M, Pastoris O, Dossena M, Aquilani R, Guerriero F, et al. (2012) Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. Int J Immunopath Ph 25: 345-353.
6. Bowen RL (2001) Sex hormones, amyloid protein, and Alzheimer disease. JAMA 286: 790-791.
7. Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004) Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol 39: 1633-1639. (Pubitemid 39576135)
8. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, et al. (2013) Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature 497: 211-216.
9. D'Amico AV, Braccioforte MH, Moran BJ, Chen MH (2010) Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer Disease. Alzheimer Dis Assoc Disord 24: 84-89
10. Nuruddin S, Wojniusz S, Ropstad E, Krogenæs A, Evans NP, et al. (2013) Peripubertal gonadotropin-releasing hormone analog treatment affects hippocampus gene expression without changing spatial orientation in young sheep. Behav Brain Res 242: 9-16.
11. Nuruddin S, Krogenæs A, Brynildsrud OB, Verhaegen S, Evans NP, et al. (2013) Peri-pubertal gonadotropin-releasing hormone agonist treatment affects sex biased gene expression of amygdala in sheep. Psychoneuroendocrinology. In press
12. Skinner DC, Albertson AJ, Navratil A, Smith A, Mignot M, et al. (2009) Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary- reproductive axis. J Neuroendocrinol 21: 282-292.
13. He D, Funabashi T, Sano A, Uemura T, Minaguchi H, et al. (1999) Effects of glucose and related substrates on the recovery of the electrical activity of gonadotropin-releasing hormone pulse generator which is decreased by insulin-induced hypoglycemia in the estrogen-primed ovariectomized rat. Brain Research 820: 71-76. (Pubitemid 29225480)
14. Lu F, Yang JM, Wu JN, Chen YC, Kao YH, et al. (1999) Activation of gonadotropin-releasing hormone receptors produces neuronal excitation in the rat hippocampus. Chin J Physiol 42: 67-71.
15. Gault PM, Maudsley S, Lincoln GA (2003) Evidence that gonadotropinreleasing hormone II is not a physiological regulator of gonadotropin secretion in mammals. J Neuroendocrinol 15: 831-839. (Pubitemid 37038608)
16. Millar RP (2005) GnRHs and GnRH receptors. Anim Reprod Sci 88: 5-28.
17. Stevenson TJ, Hahn TP, MacDougall-Shackleton SA, Ball GF (2012) Gonadotropin-releasing hormone plasticity: A comparative perspective. Front Neuroendocrin 33: 287-300.
18. Wang L, Chadwick W, Park S, Zhou Y, Silver N, et al. (2010) Gonadotropin-releasing hormone receptor system: modulatory role in aging and neurodegeneration. Cns Neurol Disord-DR 9: 651-660.
19. Bryan KJ, Mudd JC, Richardson SL, Chang J, Lee HG, et al. (2010) Downregulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits. J Neurochem 112: 870-881
20. Evans NP, Robinson JE, Erhard HW, Ropstad E, Fleming LM, et al. (2012) Development of psychophysiological motoric reactivity is influenced by peripubertal pharmacological inhibition of gonadotropin releasing hormone action-Results of an ovine model. Psychoneuroendocrinology 37: 1876-1884.
21. Wojniusz S, Vögele C, Ropstad E, Evans N, Robinson J, et al. (2011) Prepubertal gonadotropin-releasing hormone analog leads to exaggerated behavioral and emotional sex differences in sheep. Horm Behav 59: 22-27
22. Grigorova M, Sherwin BB, Tulandi T (2006) Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology 31: 935-947. (Pubitemid 44148912)
23. Nelson CJ, Lee JS, Gamboa MC, Roth AJ (2008) Cognitive effects of hormone therapy in men with prostate cancer. Cancer 113: 1097-1106.
24. Simpkins JW, Perez E, Wang X, Yang S, Wen Y, et al. (2009) Review: The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther Adv Neurol Disord 2: 31-49.
25. Wilson AC, Salamat MS, Haasl RJ, Roche KM, Karande A, et al. (2006) Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J Endocrinol 191: 651-663. (Pubitemid 46210290)
26. Lillehaug S, Syverstad GH, Nilsson LNG, Bjaalie JG, Leergaard TB, et al. (2014) Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice. Neurobiol Aging 35: 556-564.
27. Lord A, Kalimo H, Eckman C, Zhang XQ, Lannfelt L, et al. (2006) The Arctic Alzheimer mutation facilitates early intraneuronal Ab aggregation and senile plaque formation in transgenic mice. Neurobiol Aging 27: 67-77. (Pubitemid 41627951)
28. AV Schally, AM Comaru-Schally, A Nagy, M Kovacs, K Szepeshazi, et al. (2001) Hypothalamic hormones and cancer. Front Neuroendocrinol 22: 248-291 (Pubitemid 33010742)
29. Ehlers K, Halvorson L (2013) Gonadotropin- releasing hormone (GnRH) and GnRH Receptors (GnRHR). Glob libr. Women's med., ISSN: 1756-2228
30. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034.1-research0034.11.
31. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, et al. (2007) Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 35: W71-74.
32. Näslund J, Haroutunian V, Mohs R (2000) Correlation between elevated levels of amyloid b-peptide in the brain and cognitive decline. JAMA 283: 1571-1577.
33. Sedgewick J (2008) Scientific Imaging with Photoshop: Methods, Measurement, and Output. Peachpit Press, California. ISBN-10: 0321514335.
34. Badr M, Marchetti B, Pelletier G (1988) Modulation of hippocampal LHRH receptors by sex steroids in the rat. Peptides 9: 441-442. (Pubitemid 19260254)
35. Meethal S, Smith M, Bowen R, Atwood C (2005) The gonadotropin connection in Alzheimer's disease. Endocrine 26: 317-325. (Pubitemid 41271098)
36. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, et al. (2004) Luteinizing Hormone, a reproductive regulator that modulates the processing of amyloidbeta precursor protein and amyloid-beta deposition. J Biol Chem 279: 20539-20545. (Pubitemid 38623501)
37. Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, et al. (2006) Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. BBA-Mol Basis Dis 1762: 447-452. (Pubitemid 43344306)
38. Green HJ, Pakenham KI, Headley BC, Yaxley J, Nicol DL, et al. (2002) Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int 90: 427-432. (Pubitemid 36124778)
39. Cherrier MM, Rose AL, Higano C (2003) The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170: 1808-1811. (Pubitemid 37254933)
40. Sherwin BB (2003) Steroid hormones and cognitive functioning in aging men: a mini-review. J Mol Neurosci 20: 385-393
41. Marlatt MW, Webber KM, Moreira PI, Lee HG, Casadesus G, et al. (2005) Therapeutic opportunities in Alzheimer disease: One for all or all for one? Curr Med Chem 12: 1137-1147. (Pubitemid 40655270)
42. Verdile G, Laws SM, Henley D, Ames D, Bush AI, et al. (2014) Associations between gonadotropins, testosterone and b amyloid in men at risk of Alzheimer's disease. Mol Psychiatry 19: 69-75.
43. Rodrigues MA, Verdile G, Foster JK, Hogervorst E, Joesbury K, et al. (2008) Gonadotropins and Cognition in Older Women. J Alzheimers Dis 13: 267-274. (Pubitemid 352039028)
44. Barron A, Verdile G, Martins R (2006) The role of gonadotropins in Alzheimer's disease. Endocrine 29: 257-269.
45. Nogami H, Hoshino R, Ogasawara K, Miyamoto S, Hisano S (2007) Regionspecific expression and hormonal regulation of the first exon variants of rat prolactin receptor mRNA in rat brain and anterior pituitary gland. J Neuroendocrinol. 19: 583-93. (Pubitemid 47065104)